The national hotline
service hotline
0576-84273552

Introduction of R&D center


Zhejiang East Asia Pharmaceutical Co., Ltd. (Zhejiang East Asia Pharma ) is a high-tech enterprise specializing in the production of pharmaceutical raw materials (bulk drugs). It has a research unit--Shanghai Right-Hand R&D Center for Medicine, a (Zhejiang) province level research institute, and a research center of production-education-research. Zhejiang East Asia Pharma has established close exchange of production and research and cooperation with Zhejiang University, Zhejiang University of Technology, China Pharmaceutical University and Shanghai Institute of Pharmaceutical Industry etc.

Zhejiang East Asia Right-Hand R & D Center, fully qualified as Shanghai RightHand PharmTech Co., Ltd., was founded in 2006. It is located in the International Medical zoo in Zhangjiang Hi-Tech Park, Shanghai, China.



Shanghai RightHand PharmTech Co., Ltd

Shanghai RightHand PharmTech Co., Ltd, The R&D Center of Zhegjiang East-Asia Pharmaceutical Co., Ltd was established in 2006, located in the International Medical zoo in Zhangjiang Hi-Tech Park, Shanghai, China..


Right-Hand PharmTech now has a research team consisted of 25 members with doctoral and master degree, over 1200 square meters of experimental area and more than 4,000 square meters of multi-functional pilot workshop. As the R&D center of the East-Asia Pharma, Right-Hand PharmTech is engaged in project selection and determiniation of development direction and product pipeline, and implement projects until complete whole process. It is also the task of Right-Hand PharmTech to provide technical support and optimize technologies for Zhejiang East Asia Pharma in order to keep market competitiveness of the company's products. RightHand PharmTech cooperats with some of the top 10 pharmaceutical companies in the world in the model of CRO and CMO, and Accesses to customer praise.


RightHand PharmTech has a Four-story laboratory building equipped with advanced synthesis laboratory, there are more than 50 fume hoodtwo kilo-lab pilot have ten walking-in Hood, which meet the requirements of 10L, 20L, 50L reaction kettle and rotary evaporators. All instruments and equipments for analysis and detection are world-class, Every year, the company spend more than one million yuan on the experimental equipments.

RightHand PharmTech has a knowledgeable and experienced research team, specializes in the synthesis of small molecule drugs, optimization and process research and development, also focus on product quality research and drug registration both domestic and overseas. Through long-term market investigation and analysis, RightHand PharmTech has a pipeline with market prospect including therapeutics for Alzheimer's disease, Gout, Osteoporosis, Depressant and so on. Major part of DMF (FDA) document preparation and product registration declaration are completed by RightHand PharmTech.


During the past more than ten years, the RightHand PharmTech has accomplished science and technology innovation to enhance East-Asia Pharma's core competitiveness. Several patents of synthesis process have been granted. As of 2017, there are 23 authorized patents (including one PCT patent), More than a dozen patents have already entered substantive reviews.


East-Asia Pharm Provincial institute.

Since the provincial institute was approved, East-Asia Pharma actively carry out technological innovation, successively for several national, provincial, municipal science and technology projects. East-Asia Pharma has won several times award for scientific and technological progress of Zhejiang Province. It has owned 6 authorized patents and won the taizhou municipal patent demonstration enterprise honor.


Dongbang Pharm Provincial institute. The Dongbang Pharm Provincial institute has successively undertaken a number of national Torch Program projects and major provincial science and technology projects after affirmation as Zhejiang provincial high-tech enterprise on Oct. 2011. The research and development and industrialization projects of the leading products of cefaclor with core independent intellectual property rights have been successively included in the provincial major science and technology special international cooperation projects and the national Torch Program projects. It has obtained Taizhou Key enterprise technical innovation team., award of Taizhou Science and Technology Progress, award of provincial scientific and technological achievement transformation and other honors.